Welcome, Guest. Please login or register.
January 16, 2018, 08:27:45 PM

Login with username, password and session length

  • Total Posts: 725179
  • Total Topics: 59104
  • Online Today: 315
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 1
Guests: 241
Total: 242


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Medi-cal expands coverage of baseline HIV resistance testing  (Read 1703 times)

0 Members and 1 Guest are viewing this topic.

Offline J.R.E.

  • Member
  • Posts: 7,542
  • Joined Dec-2003 Living positive, since 1985.
For those on Medi-cal ( California's medicaid program)...

Medi-Cal Expands Coverage Of Baseline HIV Resistance Testing
Main Category: HIV / AIDS News
Article Date: 19 Jun 2007 - 0:00 PDT


Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that Medi-Cal has expanded its coverage of HIV resistance testing to include treatment naive patients as well as patients failing therapy. While genotypic resistance testing has traditionally been covered for patients who fail anti-HIV treatment, the expanded coverage allows for baseline genotypic resistance testing for all HIV infected patients, including those who are newly diagnosed and who are treatment naive. Medi-Cal is California's Medicaid program, which provides medical service coverage for low-income and disabled individuals.

This coverage expansion was driven by scientific evidence that documents an increasing prevalence of patients who become infected with drug resistant virus: up to 16% in some geographic areas. Drug resistant virus may persist during the pre-treatment phase of HIV infection. The BGRT identifies anti-HIV drugs likely to be ineffective, when treatment becomes necessary, even when begun months or years later. Evidence shows BGRT guided initial therapy results in longer time of viral suppression.

The evidence was compiled by physician experts whose efforts were supported by Monogram Biosciences and advocates working to better the lives of patients living with HIV. Guideline recommendations from a antiretroviral guidelines Panel convened by the Department of Health and Human Services, Office of AIDS Research Advisory Council and the Henry J. Kaiser Family Foundation documents scientific evidence that supports expanding BGRT coverage to include chronically infected HIV treatment naive patients. Specifically, the Panel recommended performing BGRT prior to initiating antiretroviral therapy in patients with acute or chronic HIV infection.

"We applaud Medi-Cal for setting coverage policies designed to bring personalized care to patients infected with HIV." says Tien Bui, Monogram Vice President of Medical Affairs. "Medi-Cal's coverage expansion is an important step towards ensuring that HIV patients and their physicians across California can make the best, most informed treatment decisions possible."

For more information on the New Policy and Frequency Restrictions for HIV Drug Resistance Testing please visit the following section of the Medi-Cal website: http://files.medi-cal.ca.gov/pubsdoco/publications/bulletins/ob/obbull_e.as .

« Last Edit: June 20, 2007, 11:45:23 AM by J.R.E. »
Current Meds ; Viramune, Epzicom, 20mg of Atorvastatin, 25 mg of Hydrochlorothiazide.
Amlodipine Besolate 5mg-- Updated 9/24/2017

Diagnosed positive in 1985,.. In October of 2003, My t-cell count was 16, Viral load was over 500,000, Percentage at that time was 5%. I started on  HAART on October 24th, 2003.

 As of 9/18/2017,  Viral load remains <40
CD 4 @358 /  CD4 % @ 13

 65 years young.


Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.